Boothbay Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,600
Closed -$5.63M 1382
2024
Q4
$5.63M Sell
21,600
-20,600
-49% -$6.11M 0.14% 210
2024
Q3
$13.6M Buy
42,200
+26,200
+164% +$8.57M 0.31% 46
2024
Q2
$5M Hold
16,000
0.12% 227
2024
Q1
$4.55M Buy
16,000
+6,700
+72% +$1.96M 0.09% 250
2023
Q4
$2.68M Buy
+9,300
New +$2.53M 0.07% 390
2022
Q3
Sell
-13,400
Closed -$3.26M 2216
2022
Q2
$3.26M Sell
13,400
-1,000
-7% -$245K 0.09% 342
2022
Q1
$3.48M Buy
+14,400
New +$3.31M 0.08% 338

Other funds holding AMGN

Boothbay Fund Management's AMGN Position: Q2 2026 in Review

Boothbay Fund Management reduced its Amgen (AMGN) stake by 35% in Q2 2026, selling an estimated $208K and leaving 1,148 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #1610.

Boothbay Fund Management first reported a position in AMGN in Q3 2015 and has held it in 16 quarters since. The position peaked at $4.92M in Q4 2025. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Boothbay Fund Management held 1,148 shares of Amgen worth $416K as of Q2 2026.
  • Boothbay Fund Management sold 607 Amgen shares in Q2 2026, an estimated $208K.
  • Amgen made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1610 holding.
  • Boothbay Fund Management first reported a position in Amgen in Q3 2015 and has held it in 16 quarters since.
  • Boothbay Fund Management's Amgen position peaked at $4.92M in Q4 2025.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.